StockGlow

Annovis Bio, Inc. (07X.F)

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States.

1.51+0.03%Healthcare
Compare 07X.F with
StockGlow Score
5
Bearish
BearishBullish
1 year ago-35.7%

The outlook

Annovis Bio, Inc. currently reads as bearish based on below its 50- & 200-day averages, 5% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range5% of the way from its 52-week low to high
Market cap
$64.2M
52-wk high
4.61
52-wk low
1.35
50-day avg
1.58
200-day avg
2.17
Trailing P/E
—

Similar stocks

0AF.FOdinwell AB (publ)$0.01-13.75%0GT.FStoke Therapeutics, Inc.$25.89+1.89%0IK.FRaspberry Pi Holdings PLC R$7.90+6.83%05Y.FVivoryon Therapeutics N.V.$1.15+0.00%08D.FMirum Pharmaceuticals, Inc.$96.10+4.84%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy